Global Platinum based Cancer Drug Market Size, Status and Forecast 2021-2027

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin in 2017 is about 71%, and the proportion is in decreasing trend from 2013 to 2017.

Market Analysis and Insights: Global Platinum based Cancer Drug Market
The global Platinum based Cancer Drug market size is projected to reach US$ 1896.4 million by 2027, from US$ 1450.8 million in 2020, at a CAGR of 3.9% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Platinum based Cancer Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Platinum based Cancer Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Platinum based Cancer Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Platinum based Cancer Drug market.

Global Platinum based Cancer Drug Scope and Market Size
Platinum based Cancer Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Platinum based Cancer Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cisplatin
Oxaliplatin
Carboplatin
Others

Segment by Application
Colorectal Cancer
Ovarian Cancer
Lung Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals